Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo M Croce

Showing results (81-90 of 599) with videos related to

Pageof 60
Sort By:
Biochimica Et Biophysica Acta|May 25, 2010
Interplay between microRNAs and the epigenetic machinery: an intricate networkMarilena V Iorio, Claudia Piovan, Carlo M Croce
Annual Review of Pathology|October 2, 2013
MicroRNAs in cancerGianpiero Di Leva, Michela Garofalo, Carlo M Croce
Signal Transduction and Targeted Therapy|June 16, 2025
Nasopharyngeal carcinoma: a model cancer to understand tumor rejectionGerard J Nuovo, Esmerina Tili, Carlo M Croce
Current Pharmaceutical Design|February 1, 2014
MicroRNAs as anti-cancer therapyMichela Garofalo, Gianpiero Di Leva, Carlo M Croce
International Reviews of Immunology|October 9, 2009
miR-155: on the crosstalk between inflammation and cancerEsmerina Tili, Carlo M Croce, Jean-Jacques Michaille
Best Practice & Research. Clinical Haematology|August 21, 2007
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemiaGeorge A Calin, Yuri Pekarsky, Carlo M Croce
JAMA|June 9, 2025
Incorrect Immunoblot in Figure Showing TP53 Downstream Effectors in Cell Lines and Primary B-Cell Chronic Lymphocytic Leukemia SamplesMuller Fabbri, George A Calin, Carlo M Croce
Cancer Journal (Sudbury, Mass.)|February 28, 2008
MicroRNAsMuller Fabbri, Carlo M Croce, George A Calin
Leukemia & Lymphoma|January 23, 2009
MicroRNAs in the ontogeny of leukemias and lymphomasMuller Fabbri, Carlo M Croce, George A Calin
Upsala Journal of Medical Sciences|February 22, 2012
MicroRNA in cancer: new hopes for antineoplastic chemotherapyGianpiero Di Leva, Daniel Briskin, Carlo M Croce
Pageof 60

Showing results (81-90 of 599) with videos related to

Sort By:
Pageof 60
Biochimica Et Biophysica Acta|May 25, 2010
Interplay between microRNAs and the epigenetic machinery: an intricate networkMarilena V Iorio, Claudia Piovan, Carlo M Croce
Annual Review of Pathology|October 2, 2013
MicroRNAs in cancerGianpiero Di Leva, Michela Garofalo, Carlo M Croce
Signal Transduction and Targeted Therapy|June 16, 2025
Nasopharyngeal carcinoma: a model cancer to understand tumor rejectionGerard J Nuovo, Esmerina Tili, Carlo M Croce
Current Pharmaceutical Design|February 1, 2014
MicroRNAs as anti-cancer therapyMichela Garofalo, Gianpiero Di Leva, Carlo M Croce
International Reviews of Immunology|October 9, 2009
miR-155: on the crosstalk between inflammation and cancerEsmerina Tili, Carlo M Croce, Jean-Jacques Michaille
Best Practice & Research. Clinical Haematology|August 21, 2007
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemiaGeorge A Calin, Yuri Pekarsky, Carlo M Croce
JAMA|June 9, 2025
Incorrect Immunoblot in Figure Showing TP53 Downstream Effectors in Cell Lines and Primary B-Cell Chronic Lymphocytic Leukemia SamplesMuller Fabbri, George A Calin, Carlo M Croce
Cancer Journal (Sudbury, Mass.)|February 28, 2008
MicroRNAsMuller Fabbri, Carlo M Croce, George A Calin
Leukemia & Lymphoma|January 23, 2009
MicroRNAs in the ontogeny of leukemias and lymphomasMuller Fabbri, Carlo M Croce, George A Calin
Upsala Journal of Medical Sciences|February 22, 2012
MicroRNA in cancer: new hopes for antineoplastic chemotherapyGianpiero Di Leva, Daniel Briskin, Carlo M Croce
Pageof 60